![](/img/cover-not-exists.png)
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
Kelly, Ciara M., Shoushtari, Alexander N., Qin, Li-Xuan, D’Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal M., Keohan, Mary Louise, Mcfadyen, Chloe, Sjoberg, Ana, Singer, Samuel, DeMatteo, RonaldLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0648-z
Date:
August, 2018
File:
PDF, 508 KB
english, 2018